Literature DB >> 20364615

Multiple myeloma presenting with multiple thoracic manifestations.

L Fekih1, S Fenniche, H Hassene, H Abdelghaffar, S Yaalaoui, F El Mezni, D Belhabib, A Zidi, M L Megdiche.   

Abstract

Multiple myeloma is a malignant proliferation of plasma cells that affects mainly bone marrow but may also involve other organs as well. We report thoracic involvement in the form of left-sided pleural effusion, osseous lesions, bronchial infiltration, and mediastinal lymphadenopathy in a 61-year-old woman, non-smoker presented with chest pain, dyspnoea, cough and deterioration in general health over the preceding seven months. Immunoelectrophoresis and immunofixation showed raised kappa-light chain immunoglobulin G (IgG) in serum and pleural fluid. Bronchial and pleural biopsies documented myelomatous infiltration and bone marrow aspirate revealed extensive plasma cell infiltration. At eight months, following the fourth cycle of melphalan, endoxan and prednisone based chemotherapy, the patient died.

Entities:  

Mesh:

Year:  2010        PMID: 20364615

Source DB:  PubMed          Journal:  Indian J Chest Dis Allied Sci        ISSN: 0377-9343


  4 in total

1.  Myelomatous Pleural Effusion: Case report and review of the literature.

Authors:  Khalil Al-Farsi; Ibrahim Al-Haddabi; Nafla Al-Riyami; Rashid Al-Sukaiti; Salam Al-Kindi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

2.  A Rare Case of Multiple Myeloma Presenting As Lytic Lesion of the Rib.

Authors:  Dhruva Sharma; Vivek Rawat; Rajkumar Yadav
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Dyspnea, massive effusion and lytic rib lesion as initial presentation of multiple myeloma in a young man.

Authors:  Mohammed H Alshati; Ramesh Kumar; Shreeram Kannan
Journal:  Can Respir J       Date:  2013 Jul-Aug       Impact factor: 2.409

4.  Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma.

Authors:  Abhishek Agarwal; Sandeep Singla; Meghana Bansal; Bijay Nair
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-25       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.